Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Document › Details

Kyoto University. (2/3/11). "Press Release: CiRA and Shimadzu Enter Research Agreement".

Region Region Japan
Organisations Organisation University of Kyoto, CiRA (Center for iPS Cell Research and Application)
  Group University of Kyoto (Kyoto University)
  Organisation 2 Shimadzu Corporation
  Group Shimadzu (Group)
Product Product  mass spectrometry (MS)
Index term Index term Shimadzu–Univ Kyoto: stem cell research, 201102– collab analysis of iPSCs + search for biomarkers using mass spectrometry CiRA
Person Person Yamanaka, Shinya (Univ Kyoto 201004– Director of CiRA + Nobel Laureate 2012)

The Kyoto University Center for iPS Cell Research and Application (CiRA) and Shimadzu Corporation have entered into a collaborative research agreement focused on the analysis of reprogramming states and the search for biomarkers in induced pluripotent stem cells (iPSCs).

Under this agreement, Shimadzu will employ mass spectrometry to study the proteomics of iPSCs biomanufactured by CiRA, and will seek to identify novel biomarkers, such as DNA, RNA, proteins, protein fragments, and small peptides, through comparative analysis of cell properties and gene expression patterns.

This research may lead to techniques for the selection of more fully reprogrammed pluripotent cells, and of higher quality target cells in induced differentiation protocols.

About CiRA

Following the generation of human iPSCs by Prof. Shinya Yamanaka and others in November 2007, Kyoto University established the Center for iPS Cell Research and Application within the Institute for Integrated Cell-Material Sciences (ICeMS) in January 2008 to further promote scientific advances in the fields of induced pluripotency and reprogramming. CiRA is the world's first institute to focus specifically on these areas, and its researchers strive to realize the potential medical benefits of these cells as rapidly as can safely and responsibly be done. CiRA became an independent institute in April 2010, under the leadership of Prof. Yamanaka.

Shimadzu Corporation

Since its establishment in 1875, Shimadzu Corp. has pursued leading-edge science and technologies in its core business areas of analytics and metrics, medical devices, aeronautics, and industrial equipment. We conduct research and development using a combination of medical applications and analytics to identify biological markers of disease, and develop molecular probes and imaging technologies to support early diagnostics and drug discovery leading to next-generation medical applications.
For more information, please visit

Record changed: 2019-06-09


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

More documents for University of Kyoto (Kyoto University)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top